LY334370
Encyclopedia
LY-334,370 is a selective 5-HT1F receptor agonist
which was under development by Eli Lilly and Company
for the treatment of migraine
headaches. The drug showed efficacy in a phase II clinical trial but further development was halted due to toxicity detected in animals.
Agonist
An agonist is a chemical that binds to a receptor of a cell and triggers a response by that cell. Agonists often mimic the action of a naturally occurring substance...
which was under development by Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company is a global pharmaceutical company. Eli Lilly's global headquarters is located in Indianapolis, Indiana, in the United States...
for the treatment of migraine
Migraine
Migraine is a chronic neurological disorder characterized by moderate to severe headaches, and nausea...
headaches. The drug showed efficacy in a phase II clinical trial but further development was halted due to toxicity detected in animals.